Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A <scp>discrete choice experiment</scp>

Abstract

These are the first systematic data obtained on WM patient preferences for treatment. The results may help discussions with individual patients about their treatment choices. Also, these data can help design clinical trials in WM and inform health-care decision-making regarding outcomes that are most relevant to patients.